ARS Pharmaceuticals reported cash from operations of -$60.93M and free cash flow of -$60.93M for the quarter ended Jun 2026, down 53.9% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -22.71M | 46.66M | -7.10M | -6.34M | -6.63M | -15.04M | -19.05M | -20.85M | -17.96M | -10.02M | -13.37M | -15.36M | -21.26M | 47.08M | -37.33M | -47.73M | -53.15M | -41.33M | -62.81M | -63.99M | ||||||
| Share-based CompensationStock Comp. | 9.56M | -11.21M | 11.32M | 11.32M | 11.32M | 4.76M | 15.58M | 15.38M | 14.91M | 2.28M | 14.40M | 14.44M | 15.18M | 4.26M | 17.35M | 17.27M | 17.11M | 5.74M | 20.33M | 46.90M | ||||||
| Gains from Investment SecuritiesGains Investment | -0.00M | -0.00M | 0.14M | |||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -19.12M | 27.89M | -6.92M | -6.97M | -5.68M | -20.50M | -12.43M | -16.67M | -12.76M | -17.41M | -6.71M | -7.28M | -14.47M | 42.00M | -40.74M | -39.59M | -47.05M | -43.48M | -44.95M | -60.93M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.34M | 0.24M | 0.28M | -1.81M | -1.75M | -1.56M | -1.73M | -1.98M | 5.86M | 1.83M | 1.54M | 1.96M | 1.47M | 1.09M | 1.00M | 0.99M | 0.65M | |||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.21M | 0.10M | 0.01M | 0.02M | 0.10M | 0.03M | 0.28M | 0.28M | 0.39M | 0.42M | 0.40M | 0.42M | ||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.77M | 7.40M | 1.13M | 13.25M | 14.01M | -11.18M | 0.84M | 20.63M | ||||||||||||||||||
| Change in InventoryChange Inventory | 0.18M | 5.76M | 8.45M | 4.78M | -0.96M | 9.72M | 0.29M | -0.01M | ||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.37M | -5.45M | 0.55M | -0.27M | 0.86M | -11.42M | 4.76M | 0.22M | 1.12M | -8.88M | 1.34M | 3.07M | 4.34M | 7.66M | 4.17M | 12.81M | 10.96M | -9.06M | 10.31M | 10.52M | ||||||
| Other Working Capital ChangesOther WC Changes | -0.66M | -0.46M | -0.19M | -3.13M | -0.01M | 2.09M | -0.21M | -0.03M | -0.06M | -0.06M | -0.06M | -0.03M | ||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.09M | -0.77M | 0.02M | 0.02M | 0.03M | 0.13M | 0.19M | 0.03M | 0.04M | -0.09M | 0.08M | 0.04M | 0.14M | 0.30M | 0.09M | 0.05M | 0.20M | |||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 20.00M | 45.00M | 60.00M | 60.00M | 55.00M | 75.00M | 61.00M | 67.00M | 63.50M | 80.00M | 88.50M | 75.00M | 42.50M | 61.48M | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -40.06M | 40.74M | -0.02M | -0.02M | -0.03M | -0.13M | -111.55M | 44.97M | -46.64M | 26.04M | -8.51M | -12.65M | 16.82M | -101.76M | 29.06M | 48.57M | -44.98M | 24.11M | 27.79M | 41.57M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.15M | -1.02M | 0.29M | 0.28M | 1.32M | 2.85M | 0.92M | 1.80M | 0.26M | 0.55M | 0.68M | 1.53M | 0.72M | 2.70M | 0.48M | 1.78M | 0.06M | 0.79M | ||||||||
| Cash from Financing ActivitiesCash from Financing | 0.15M | 52.82M | -0.91M | -0.62M | -1.56M | 193.82M | 1.32M | 2.85M | 0.92M | 1.80M | 0.26M | 0.55M | 0.68M | 70.92M | 0.72M | 2.70M | 100.05M | 1.13M | 0.16M | 3.20M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.51M | 1.83M | 1.47M | 4.10M | 4.75M | 3.07M | 5.32M | 2.64M | 3.36M | 3.70M | ||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 54.81M | |||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Change in Cash | -59.03M | 121.45M | -7.85M | -7.62M | -7.27M | 173.20M | -122.66M | 31.16M | -58.48M | 10.44M | -14.96M | -19.38M | 3.03M | 11.16M | -10.95M | 11.68M | 8.02M | -18.24M | -17.00M | -16.16M | ||||||
| Free Cash FlowFCF | -19.21M | 28.66M | -6.95M | -7.00M | -5.71M | -20.62M | -12.62M | -16.70M | -12.81M | -17.31M | -6.79M | -7.32M | -14.61M | 41.70M | -40.83M | -39.64M | -47.24M | -43.48M | -44.95M | -60.93M | ||||||
| Net Cash FlowNCF | -59.03M | 121.45M | -7.85M | -7.62M | -7.27M | 173.20M | -122.66M | 31.16M | -58.48M | 10.44M | -14.96M | -19.38M | 3.03M | 11.16M | -10.95M | 11.68M | 8.02M | -18.24M | -17.00M | -16.16M |